The population of the US is not vaccinated but many immigrants who enter the US do have a BCG vaccination. These people are also at the lower end of the economy are are susceptible to latent TB being activated.
In my research I did find a paper that questioned the effectiveness of the proteins being used in QF-1. Moreover, there needed to be a powerful impetus to change from the established skin test. I was not fully convinced that QF-1 had the muscle to drive the change.
On the other hand the link to SSI has resulted in QF-Gold which does satisfy my criteria. It also extends the patents [courtesy of SSI]. This removes the risk of a generic test after only several years of marketing QF-1 by CST.
QF-Gold has technical and commercial advantages that puts QF-1 in the shade. The wait may be longer but the benefits are greater.
The population of the US is not vaccinated but many immigrants...
Add to My Watchlist
What is My Watchlist?
